nifedipine has been researched along with nicotine in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.88) | 18.7374 |
| 1990's | 19 (37.25) | 18.2507 |
| 2000's | 18 (35.29) | 29.6817 |
| 2010's | 11 (21.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Berg, DK; Pugh, PC; Rathouz, MM; Vijayaraghavan, S; Zhang, ZW | 1 |
| Atkinson, J; Bray-des Boscs, L; Capdeville-Atkinson, C; Chillon, JM; Hoffman, M; Lartaud, I; Makki, T; Nicolas, JP | 1 |
| Higo, K; Karasawa, A; Kubo, K | 1 |
| Kato, R; Nakaki, T; Sasakawa, N | 1 |
| Höllt, V; Kley, N; Loeffler, JP; Pittius, CW | 1 |
| Höllt, V; Kley, N; Loeffler, JP | 1 |
| Forsberg, EJ; Pollard, HB | 1 |
| Munekata, E; Takenouchi, T | 1 |
| Nishimura, S; Sorimachi, M; Yamagami, K | 2 |
| Sorimachi, M | 1 |
| Arneric, SP; Donnelly-Roberts, DL; Sullivan, JP | 1 |
| Abe, Y; Akaike, N; Furukawa, K; Sorimachi, M | 1 |
| Czirfuzs, A; Fleckenstein-Grün, G; Frey, M; Matyas, S; Thimm, F | 1 |
| Chin, CW; Wong, JO; Wu, WH; Zbuzek, VK | 1 |
| Desrues, L; Garnier, M; Lamacz, M; Louiset, E; Tonon, MC; Vaudry, H | 1 |
| Korbmacher, C; Korf, HW; Letz, B; Maronde, E; Schomerus, C | 1 |
| Cohen, B; Wu, W; Zbuzek, VK | 1 |
| Fitzgerald, RS; Sham, JS; Shirahata, M | 1 |
| Koizumi, S; Moriyama, Y; Ogura, A; Yamada, H; Yamaguchi, A | 1 |
| Hunt, TE; Wu, WH; Zbuzek, VK | 1 |
| Aono, Y; Ariyoshi, H; Kawasaki, T; Monden, M; Sakon, M; Tsuji, Y; Ueda, A | 1 |
| Changeux, JP; Klink, R; Korn, H; Léna, C; Tsuneki, H | 1 |
| Gerzanich, V; Simard, JM; West, GA; Zhang, F | 1 |
| Chen, RZ; Deng, CY; He, J; Yu, JP; Zhu, XN | 1 |
| Hatanaka, H; Ikeuchi, T; Nakayama, H; Numakawa, T | 1 |
| Fitzsimonds, RM; Krueger, SR; Picciotto, MR; Stevens, TR | 1 |
| Gordon, H; Milholland, RB | 1 |
| Ito, K; Jia, Y; Nakauchi, S; Sumikawa, K; Yamazaki, Y | 1 |
| Barry, NG; Fife, JA; Fink, BF; Milan, ME; Rinker, B | 1 |
| Kang, P; Lee, HS; Min, SS; Moon, HK; Seol, GH | 1 |
| Bernardi, RE; Hansson, AC; Spanagel, R; Uhrig, S | 1 |
2 review(s) available for nifedipine and nicotine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
49 other study(ies) available for nifedipine and nicotine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+.
Topics: Animals; Bungarotoxins; Cadmium; Calcium; Calcium Channels; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Fluorescence; Neurons; Nickel; Nicotine; Nifedipine; Receptors, Nicotinic; Tubocurarine | 1992 |
Haemodynamic effects of a new dihydropyridine calcium entry blocker, S-12968-(-), in a rat model of cardiovascular calcium overload.
Topics: Animals; Blood Pressure; Body Weight; Calcium; Calcium Channel Blockers; Cardiac Output; Cholecalciferol; Dihydropyridines; Heart Rate; Hemodynamics; Magnesium; Male; Nicotine; Nifedipine; Nitroprusside; Rats; Stereoisomerism; Vascular Resistance | 1992 |
Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta; Arteries; Calcinosis; Calcium; Calcium Channel Blockers; Endothelium, Vascular; Ergocalciferols; Male; Microscopy, Electron, Scanning; Muscle Relaxation; Muscle, Smooth, Vascular; Nicotine; Nifedipine; Rats; Rats, Inbred Strains | 1992 |
Stimulus-responsive and rapid formation of inositol pentakisphosphate in cultured adrenal chromaffin cells.
Topics: Adrenal Medulla; Animals; Calcium; Cattle; Cells, Cultured; Chromatography, High Pressure Liquid; Egtazic Acid; Endothelins; Inositol; Inositol Phosphates; Kinetics; Lithium; Marine Toxins; Nicotine; Nifedipine; Oxocins; Platelet-Derived Growth Factor; Potassium; Tetradecanoylphorbol Acetate; Veratridine | 1990 |
Involvement of ion channels in the induction of proenkephalin A gene expression by nicotine and cAMP in bovine chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Glands; Animals; Calcium; Cattle; Cells, Cultured; Chromaffin System; Colforsin; Cyclic AMP; Enkephalins; Gallopamil; Gene Expression Regulation; Ion Channels; Nicotine; Nifedipine; Protein Precursors; RNA, Messenger; Sodium; Tubocurarine; Verapamil | 1987 |
Ca2+-dependent histaminergic regulation of proenkephalin mRNA levels in cultured adrenal chromaffin cells.
Topics: Adrenal Medulla; Animals; Calcium; Cattle; Cells, Cultured; Enkephalins; Gallopamil; Histamine; Ion Channels; Nicotine; Nifedipine; Nucleic Acid Hybridization; Protein Precursors; RNA, Messenger | 1987 |
Ba2+-induced ATP release from adrenal medullary chromaffin cells is mediated by Ba2+ entry through both voltage- and receptor-gated Ca2+ channels.
Topics: Adenosine Triphosphate; Adrenal Medulla; Animals; Barium; Calcium Channels; Cattle; Firefly Luciferin; Fluorescent Dyes; Hexamethonium; Hexamethonium Compounds; Nicotine; Nifedipine; Potassium; Receptors, Nicotinic | 1988 |
Inhibitory effects of beta-amyloid peptides on nicotine-induced Ca2+ influx in PC12h cells in culture.
Topics: Amino Acid Sequence; Amyloid beta-Peptides; Animals; Calcium; Cells, Cultured; Cytoplasm; Molecular Sequence Data; Nicotine; Nifedipine; PC12 Cells; Peptide Fragments; Potassium; Rats; Receptors, Nicotinic; Substance P | 1994 |
Inability of Ca2+ influx through nicotinic ACh receptor channels to stimulate catecholamine secretion in bovine adrenal chromaffin cells: studies with fura-2 and SBFI microfluorometry.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Animals; Calcium; Calcium Channels; Catecholamines; Cations, Divalent; Cattle; Clonidine; Cytophotometry; Dose-Response Relationship, Drug; Electrophysiology; Fura-2; Gallopamil; Guanethidine; Hexamethonium; Manganese; Nicotine; Nifedipine; Oxotremorine; Receptors, Nicotinic; Sodium; Spectrometry, Fluorescence | 1994 |
Pharmacology of nicotine-induced increase in cytosolic Ca2+ concentrations in chick embryo ciliary ganglion cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atropine; Calcium; Calcium Channel Blockers; Chick Embryo; Cytophotometry; Fura-2; Gallopamil; Ganglia, Parasympathetic; Manganese; Nicotine; Nifedipine | 1995 |
Functional modulation of human "ganglionic-like" neuronal nicotinic acetylcholine receptors (nAChRs) by L-type calcium channel antagonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Cadmium; Calcium Channel Blockers; Calcium Channels; Diltiazem; Humans; Isradipine; Neuroblastoma; Neurons; Nicotine; Nifedipine; Nimodipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Receptors, Nicotinic; Spider Venoms; Tumor Cells, Cultured; Verapamil | 1995 |
Mechanism underlying the ATP-induced increase in the cytosolic Ca2+ concentration in chick ciliary ganglion neurons.
Topics: Adenosine Triphosphate; Animals; Calcium; Chick Embryo; Cytosol; Gallopamil; Ganglia, Parasympathetic; In Vitro Techniques; Ion Channel Gating; Nicotine; Nifedipine; omega-Conotoxin GVIA; Peptides; Potassium; Purines; Receptors, Nicotinic; Receptors, Purinergic; Sodium | 1995 |
Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cells, Cultured; Cholecalciferol; Cholesterol; Coronary Vessels; Diltiazem; Disease Models, Animal; Humans; Hypertension; Middle Aged; Muscle, Smooth, Vascular; Nicotine; Nifedipine; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Risk Factors; Verapamil | 1994 |
Cd2+ and Co2+ at micromolar concentrations stimulate catecholamine secretion by increasing the cytosolic free Ca2+ concentration in cat adrenal chromaffin cells.
Topics: Adrenal Medulla; Animals; Cadmium; Calcium; Catecholamines; Cats; Cobalt; Cytosol; Gallopamil; In Vitro Techniques; Microchemistry; Nicotine; Nifedipine; Potassium Chloride | 1994 |
The effect of nifedipine and verapamil on nicotine-induced antinociception in rats.
Topics: Analgesia; Animals; Drug Synergism; Male; Nicotine; Nifedipine; Nociceptors; Pain Measurement; Rats; Rats, Sprague-Dawley; Verapamil | 1994 |
Nicotine-induced stimulation of alpha-MSH release in frog pituitary melanotrophs is mediated through a novel type of receptor.
Topics: alpha-MSH; Animals; Atropine; Calcium; Gallamine Triethiodide; In Vitro Techniques; Muscarine; Nicotine; Nifedipine; Pirenzepine; Pituitary Gland, Posterior; Ranidae; Receptors, Muscarinic; Tetrodotoxin | 1993 |
Stimulation of a nicotinic ACh receptor causes depolarization and activation of L-type Ca2+ channels in rat pinealocytes.
Topics: Acetylcholine; Animals; Calcium; Calcium Channels; Charybdotoxin; Large-Conductance Calcium-Activated Potassium Channels; Microscopy, Fluorescence; Nicotine; Nifedipine; Pineal Gland; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Chloride; Rats; Receptors, Nicotinic; Sodium Chloride | 1997 |
Antinociceptive effect of nifedipine and verapamil tested on rats chronically exposed to nicotine and after its withdrawal.
Topics: Analgesics; Animals; Male; Nicotine; Nifedipine; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Verapamil | 1997 |
Acetylcholine increases intracellular calcium of arterial chemoreceptor cells of adult cats.
Topics: Acetylcholine; Animals; Calcium; Carotid Body; Cats; Cells, Cultured; Chemoreceptor Cells; Fluorescent Dyes; Indoles; Kinetics; Mecamylamine; Muscarine; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Nifedipine; Pilocarpine; Potassium | 1997 |
Acetylcholine triggers L-glutamate exocytosis via nicotinic receptors and inhibits melatonin synthesis in rat pinealocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Arylamine N-Acetyltransferase; Atropine; Bungarotoxins; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Carbachol; Cells, Cultured; Diltiazem; Exocytosis; Glutamic Acid; Melatonin; Muscarine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nifedipine; Nitrendipine; Oxotremorine; Parasympathetic Nervous System; Pineal Gland; Rats; Rats, Wistar; Receptors, Nicotinic; Scopolamine; Synaptic Vesicles; Tubocurarine | 1998 |
The effects of serotonin biosynthesis inhibition on nicotine and nifedipine-induced analgesia in rats.
Topics: Analgesics, Non-Narcotic; Animals; Area Under Curve; Brain Chemistry; Calcium Channel Blockers; Fenclonine; Male; Nicotine; Nicotinic Agonists; Nifedipine; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Serotonin Antagonists | 1998 |
Human umbilical vein endothelial cells (HUVECs) show Ca(2+) mobilization as well as Ca(2+) influx upon hypoxia.
Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Egtazic Acid; Endothelium, Vascular; Estrenes; Female; Humans; Hypoxia; Microscopy, Confocal; Nicardipine; Nicotine; Nifedipine; Pyrrolidinones; Type C Phospholipases; Umbilical Veins | 2000 |
Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aconitine; Action Potentials; Animals; Benzoates; Bungarotoxins; Calcium; Calcium Channel Blockers; Choline; Dihydro-beta-Erythroidine; Endoplasmic Reticulum; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Fura-2; Glycine; In Vitro Techniques; Indoles; Insecticides; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurons; Nicotine; Nicotinic Agonists; Nifedipine; Nootropic Agents; Patch-Clamp Techniques; Polyamines; Presynaptic Terminals; Receptors, Nicotinic; Substantia Nigra; Tetrodotoxin; Tyrosine 3-Monooxygenase | 2000 |
Chronic nicotine alters NO signaling of Ca(2+) channels in cerebral arterioles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Barium; Calcium; Calcium Channels; Calcium Channels, L-Type; Cerebral Arteries; Cerebrovascular Circulation; Cyclic GMP; Dihydropyridines; Electric Stimulation; Female; Membrane Potentials; Muscle, Smooth, Vascular; Nicotine; Nifedipine; Nitric Oxide; Nitroprusside; Potassium Channels; Rats; Rats, Inbred WKY; Signal Transduction; Time Factors; Tyrphostins | 2001 |
Long-term potentiation induced by nicotine in CA1 region of hippocampal slice is Ca(2+)-dependent.
Topics: Animals; Calcium Channel Blockers; Female; Hippocampus; Long-Term Potentiation; Male; Nicotine; Nifedipine; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Thapsigargin | 2000 |
Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells.
Topics: Aconitine; Animals; Benzylamines; Bungarotoxins; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Hexamethonium; Insecticides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nifedipine; PC12 Cells; Phosphorylation; Potassium; ras Proteins; Rats; Receptors, Nicotinic; Sulfonamides; Tubocurarine | 2001 |
Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bungarotoxins; Calcineurin; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Cerebral Cortex; Glutamic Acid; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Neurotoxins; Nicotine; Nifedipine; Receptors, Nicotinic; Tacrolimus | 2003 |
A role for acetylcholine receptors in their own aggregation on muscle cells.
Topics: Agrin; Animals; Calcium Channels, L-Type; Curare; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Nicotine; Nifedipine; Phosphorylation; Phosphotyrosine; Protein Subunits; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Signal Transduction | 2007 |
Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors.
Topics: Animals; Calcium; Calcium Channel Blockers; Chelating Agents; Egtazic Acid; Excitatory Postsynaptic Potentials; Hippocampus; Interneurons; Long-Term Potentiation; Nicotine; Nicotinic Agonists; Nifedipine; Patch-Clamp Techniques; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Ryanodine; Synapses | 2010 |
The effect of calcium channel blockers on smoking-induced skin flap necrosis.
Topics: Animals; Calcium Channel Blockers; Cotinine; Graft Survival; Male; Necrosis; Nicotine; Nifedipine; Rats; Rats, Wistar; Smoking; Surgical Flaps; Vasodilation; Verapamil | 2010 |
Effects of 1,8-cineole on hypertension induced by chronic exposure to nicotine in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclohexanols; Eucalyptol; Eucalyptus; Hypertension; Male; Monoterpenes; Nicotine; Nifedipine; Nitric Oxide; Nitrites; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley | 2014 |
Transcriptional regulation of L-type calcium channel subtypes Cav1.2 and Cav1.3 by nicotine and their potential role in nicotine sensitization.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Nifedipine; Prosencephalon; Up-Regulation | 2014 |